The cancer detection rate was 3.2 per 1,000 women without CAD and 3.8 per 1,000 women with CAD.
The probability of a palpable mass was 0.01576.
The percentage of women detected with Stage 0 breast cancer was 29.3% with mammography alone, 34.7% with CAD and 11% with clinical detection.
The corresponding figures for Stage 4 were 2.4% with mammography alone, 2.0% with CAD and 7% with clinical detection.
Survival was 100% with Stage 0 cancer and 16% with Stage 4 cancer.
The recall for abnormal screening was 0.065 without CAD and 0.077 with CAD.
The positive predictive value of biopsy was 0.38.